Expressing support for the designation of November 2024 as "National Lung Cancer Awareness Month" and expressing support for early detection and treatment of lung cancer.

Legislation Details

Supports the designation of November 2024 as “National Lung Cancer Awareness Month.”
Highlights lung cancer as the leading cause of cancer-related deaths in the U.S.
Estimates 234,580 new lung cancer diagnoses and 125,070 deaths in 2024.
Notes that 1 in 16 men and 1 in 17 women will develop lung cancer in their lifetimes.
Reports a 92% increase in lung cancer death rates among women from 1971 to 2021.
States that more women die from lung cancer than from breast and ovarian cancers combined.
Indicates that nonsmokers, particularly women, are increasingly diagnosed with lung cancer.
Mentions that 20,300 lung cancer deaths in 2024 will be unrelated to smoking.
Points out that 81% of lung cancer deaths are caused by smoking, with secondhand smoke contributing to over 7,300 deaths annually.
Discusses the disparity in survival rates based on the stage of diagnosis (65% for localized vs. 9% for advanced).
Notes that only 5.8% of high-risk individuals undergo lung cancer screening.
Identifies geographic and transportation barriers to screening access.
Highlights a lack of awareness about lung cancer screening among nearly 70% of adults.
States that lung cancer is the second most commonly diagnosed cancer in veterans, who are at a higher risk.
Emphasizes that Black men have the highest incidence and mortality rates for lung cancer.
Mentions changes to screening guidelines that expanded eligibility for lung cancer screening.
Addresses the stigma surrounding lung cancer, which creates barriers to diagnosis, treatment, and research.
Acknowledges advancements in lung cancer research, including biomarker identification and new therapies.
Encourages educational efforts to raise awareness about lung cancer and screening.

Expressing support for the designation of November 2024 as "National Lung Cancer Awareness Month" and expressing support for early detection and treatment of lung cancer.

Cosponsors